EVANS JOHN RAYMOND,GRUNDY ROSALIND URSULA,EVANS John Raymond,GRUNDY Rosalind Ursula
申请号：
SI200130446
公开号：
SI1250138T2
申请日:
2001.01.08
申请国别(地区):
SI
年份:
2015
代理人:
摘要：
The invention relates to a novel sustained release pharmaceutical formulation adapted for administration by injection containing the compound 7±-[9-(4,4,5,5,5-pentafluoropentylsulphmyl)nonyl]oestra-1,3,5(10)-thene-3,17²-diol, more particularly to a formulation adapted for administration by injection containing the compound 7±-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17²-diol in solution in a ricinoleate vehicle which additionally comprises at least one alcohol and a non-aqueous ester solvent which is miscible in the ricinoleate vehicle.
